DOI: 10.36347/sjams.2019.v07i09.053

Pages: 3184-3187

Malignant tumors of the small intestine (MTSI) are rare. They account for 1-5% of all tumors of the digestive tract. They are characterised by a heterogeneous anatomopathology and a poor and non-specific symptomatology resulting in delayed diagnosis, therapeutic difficulties and therefore poor prognosis. We report the epidemiological, diagnostic and therapeutic characteristics of patients with MTSI in the visceral surgery department of university hospital Mohammed VI. This is a retrospective review of the clinical records of the 62 patients diagnosed with malignant small bowel tumors admitted to our service between 2000 and 2016. Median age was 50 years (40-60 years). The median time to diagnosis was 6 months (0-96 months). Abdominal pain was the most common symptom (77.8%). The anatomopathological study showed 41.93% adenocarcinoma, 20.96% non-Hodgkin lymphoma, 17.74% stromal tumor, 16.1% carcinoid and 3.22% epidermoidal carcinoma. 57 patients (91.93%) had surgical resection and 22 patients (35. 4%) had chemotherapy depending on stage of disease and histological type. Malignant tumors of the small intestine are rare. Their diagnosis is late limiting the therapeutic management. Clinicians should be warned of non-specific gastrointestinal symptoms.